After Madisch et al. provided convincing evidence for a proprietary combination of peppermint and caraway oil for functional gastrointestinal disorders (FGID) in a meta-analysis, Storr et al. recently conducted a subgroup analysis of this data. This showed that FGID patients benefit from the phytotherapeutic agent regardless of age and gender.
Autoren
- Mirjam Peter, M.Sc.
Publikation
- HAUSARZT PRAXIS
Related Topics
You May Also Like
- COPD therapy
Drug therapy – Update 2025
- Pulmonary hypertension
PH and lung diseases
- IBDmatters - Synergy effects for IBD pathways
How combination therapies lead to better treatment results
- Focus on prevention
Colorectal cancer screening – an update
- Chronic hand eczema
Topical pan-JAK-i vs. systemic retinoid: head-to-head study
- Study report
Long-term data on CFTR modulators in children with cystic fibrosis
- Multiple sclerosis
Multiple sclerosis 2025: New strategies against progression and the role of microglia
- A syndrome between decompensation and chronification